Synaptogenix, Inc. (SNPX)
NASDAQ: SNPX · Real-Time Price · USD
2.432
+0.012 (0.51%)
At close: Apr 1, 2025, 4:00 PM
2.562
+0.130 (5.34%)
After-hours: Apr 1, 2025, 4:04 PM EDT
Synaptogenix Market Cap
Synaptogenix has a market cap or net worth of $3.30 million as of April 1, 2025. Its market cap has decreased by -9.66% in one year.
Market Cap
3.30M
Enterprise Value
-14.57M
1-Year Change
-9.66%
Ranking
Category
Stock Price
$2.43
Market Cap Chart
Since December 15, 2020, Synaptogenix's market cap has decreased from $5.28M to $3.30M, a decrease of -37.57%. That is a compound annual growth rate of -10.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2025 | 3.30M | -29.90% |
| Dec 31, 2024 | 4.70M | -15.16% |
| Dec 29, 2023 | 5.54M | -34.23% |
| Dec 30, 2022 | 8.43M | -85.16% |
| Dec 31, 2021 | 56.80M | 652.77% |
| Dec 31, 2020 | 7.55M | 42.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 716.47B |
| UnitedHealth Group | 476.97B |
| Johnson & Johnson | 372.71B |
| AbbVie | 365.75B |
| Novo Nordisk | 302.16B |
| AstraZeneca | 227.81B |
| Abbott Laboratories | 227.47B |
| Merck & Co. | 219.71B |